Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYFive-year ILLUMENATE EU RCT and Pivotal study results confirm safety profile of Philips Stellarex .035” low-dose drug-coated balloonPREV STORYIterum Therapeutics Announces U.S. FDA Filing Acceptance of New Drug Application for Oral Sulopenem